FLT3-ITD expression levels and their effect on STAT5 in AML with and without NPM mutations

British Journal of Haematology

Volumn 147, Issue 5, 2009, Pages 653-661

  Seedhouse, Claire H ^a   Pallis, Monica ^a   Grundy, Martin ^a   Shang, Shili ^a   Russell, Nigel H ^a  

^a NOTTINGHAM UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

Author keywords

Acute myeloid leukaemia; Bcl xl; FLT3; NPM; Signal transducer and activator of transcription 5

Indexed keywords

CD135 ANTIGEN; NUCLEOPHOSMIN; PROTEIN BCL XL; STAT5 PROTEIN;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOPLASM; GENE EXPRESSION; HUMAN; MAJOR CLINICAL STUDY; MUTATIONAL ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION;

BCL-X PROTEIN; DNA MUTATIONAL ANALYSIS; FMS-LIKE TYROSINE KINASE 3; GENE DUPLICATION; HUMANS; LEUKEMIA, MYELOID, ACUTE; MIDDLE AGED; MUTATION; NEOPLASM PROTEINS; NUCLEAR PROTEINS; PHOSPHORYLATION; POLYMERASE CHAIN REACTION; STAT5 TRANSCRIPTION FACTOR; TANDEM REPEAT SEQUENCES;

EID: 70449362059     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2009.07901.x     Document Type: Article

References (43)

1. Bacher, U., Haferlach, C., Kern, W., Haferlach, T. Schnittger, S. (2008) Prognostic relevance of FLT3-TKD mutations in AML: the combination matters - an analysis of 3082 patients. Blood, 111, 2527 2537.
2. Birkenkamp, K.U., Geugien, M., Lemmink, H.H., Kruijer, W. Vellenga, E. (2001) Regulation of constitutive STAT5 phosphorylation in acute myeloid leukemia blasts. Leukemia, 15, 1923 1931.
3. Bunting, K.D., Xie, X.Y., Warshawsky, I. Hsi, E.D. (2007) Cytoplasmic localization of phosphorylated STAT5 in human acute myeloid leukemia is inversely correlated with Flt3-ITD. Blood, 110, 2775 2776.
4. Choudhary, C., Schwable, J., Brandts, C., Tickenbrock, L., Sargin, B., Kindler, T., Fischer, T., Berdel, W.E., Muller-Tidow, C. Serve, H. (2005) AML-associated Flt3 kinase domain mutations show signal transduction differences compared with Flt3 ITD mutations. Blood, 106, 265 273.
5. Dohner, K., Schlenk, R.F., Habdank, M., Scholl, C., Rucker, F.G., Corbacioglu, A., Bullinger, L., Frohling, S. Dohner, H. (2005) Mutant nucleophosmin (NPM1) predicts favorable prognosis in younger adults with acute myeloid leukemia and normal cytogenetics: interaction with other gene mutations. Blood, 106, 3740 3746.
6. Dumon, S., Santos, S.C., Debierre-Grockiego, F., Gouilleux-Gruart, V., Cocault, L., Boucheron, C., Mollat, P., Gisselbrecht, S. Gouilleux, F. (1999) IL-3 dependent regulation of Bcl-xL gene expression by STAT5 in a bone marrow derived cell line. Oncogene, 18, 4191 4199.
7. Falini, B., Mecucci, C., Tiacci, E., Alcalay, M., Rosati, R., Pasqualucci, L., La Starza, R., Diverio, D., Colombo, E., Santucci, A., Bigerna, B., Pacini, R., Pucciarini, A., Liso, A., Vignetti, M., Fazi, P., Meani, N., Pettirossi, V., Saglio, G., Mandelli, F., Lo-Coco, F., Pelicci, P.G. Martelli, M.F. (2005) Cytoplasmic nucleophosmin in acute myelogenous leukemia with a normal karyotype. New England Journal of Medicine, 352, 254 266. (Pubitemid 40110814)
8. Falini, B., Nicoletti, I., Martelli, M.F. Mecucci, C. (2007) Acute myeloid leukemia carrying cytoplasmic/mutated nucleophosmin (NPMc+ AML): biologic and clinical features. Blood, 109, 874 885.
9. Gale, R.E., Green, C., Allen, C., Mead, A.J., Burnett, A.K., Hills, R.K. Linch, D.C. (2008) The impact of FLT3 internal tandem duplication mutant level, number, size, and interaction with NPM1 mutations in a large cohort of young adult patients with acute myeloid leukemia. Blood, 111, 2776 2784.
10. Gesbert, F. Griffin, J.D. (2000) Bcr/Abl activates transcription of the Bcl-X gene through STAT5. Blood, 96, 2269 2276.
11. Griffiths, M., Mason, J., Rindl, M., Akiki, S., McMullan, D., Stinton, V., Powell, H., Curtis, A., Bown, N. Craddock, C. (2005) Acquired isodisomy for chromosome 13 is common in AML, and associated with FLT3-itd mutations. Leukemia, 19, 2355 2358.
12. Grisendi, S., Mecucci, C., Falini, B. Pandolfi, P.P. (2006) Nucleophosmin and cancer. Nature Reviews Cancer, 6, 493 505.
13. Gupta, M., Raghavan, M., Gale, R.E., Chelala, C., Allen, C., Molloy, G., Chaplin, T., Linch, D.C., Cazier, J.B. Young, B.D. (2008) Novel regions of acquired uniparental disomy discovered in acute myeloid leukemia. Genes, Chromosomes and Cancer, 47, 729 739.
14. Harir, N., Pecquet, C., Kerenyi, M., Sonneck, K., Kovacic, B., Nyga, R., Brevet, M., Dhennin, I., Gouilleux-Gruart, V., Beug, H., Valent, P., Lassoued, K., Moriggl, R. Gouilleux, F. (2007) Constitutive activation of Stat5 promotes its cytoplasmic localization and association with PI3-kinase in myeloid leukemias. Blood, 109, 1678 1686.
15. Hayakawa, F., Towatari, M., Kiyoi, H., Tanimoto, M., Kitamura, T., Saito, H. Naoe, T. (2000) Tandem-duplicated Flt3 constitutively activates STAT5 and MAP kinase and introduces autonomous cell growth in IL-3-dependent cell lines. Oncogene, 19, 624 631.
16. Irish, J.M., Hovland, R., Krutzik, P.O., Perez, O.D., Bruserud, O., Gjertsen, B.T. Nolan, G.P. (2004) Single cell profiling of potentiated phospho-protein networks in cancer cells. Cell, 118, 217 228.
17. Kiyoi, H., Naoe, T., Nakano, Y., Yokota, S., Minami, S., Miyawaki, S., Asou, N., Kuriyama, K., Jinnai, I., Shimazaki, C., Akiyama, H., Saito, K., Oh, H., Motoji, T., Omoto, E., Saito, H., Ohno, R. Ueda, R. (1999) Prognostic implication of FLT3 and N-RAS gene mutations in acute myeloid leukemia. Blood, 93, 3074 3080.
18. Kottaridis, P.D., Gale, R.E., Frew, M.E., Harrison, G., Langabeer, S.E., Belton, A.A., Walker, H., Wheatley, K., Bowen, D.T., Burnett, A.K., Goldstone, A.H. Linch, D.C. (2001) The presence of a FLT3 internal tandem duplication in patients with acute myeloid leukemia (AML) adds important prognostic information to cytogenetic risk group and response to the first cycle of chemotherapy: analysis of 854 patients from the United Kingdom Medical Research Council AML 10 and 12 trials. Blood, 98, 1752 1759.
19. Kuchenbauer, F., Kern, W., Schoch, C., Kohlmann, A., Hiddemann, W., Haferlach, T. Schnittger, S. (2005) Detailed analysis of FLT3 expression levels in acute myeloid leukemia. Haematologica, 90, 1617 1625.
20. Kusec, R., Jaksic, O., Ostojic, S., Kardum-Skelin, I., Vrhovac, R. Jaksic, B. (2006) More on prognostic significance of FLT3/ITD size in acute myeloid leukemia (AML). Blood, 108, 405 406 author reply 406.
21. Levis, M. Small, D. (2003) FLT3: ITDoes matter in leukemia. Leukemia, 17, 1738 1752.
22. Libura, M., Asnafi, V., Tu, A., Delabesse, E., Tigaud, I., Cymbalista, F., Bennaceur-Griscelli, A., Villarese, P., Solbu, G., Hagemeijer, A., Beldjord, K., Hermine, O. Macintyre, E. (2003) FLT3 and MLL intragenic abnormalities in AML reflect a common category of genotoxic stress. Blood, 102, 2198 2204.
23. Minami, Y., Yamamoto, K., Kiyoi, H., Ueda, R., Saito, H. Naoe, T. (2003) Different antiapoptotic pathways between wild-type and mutated FLT3: insights into therapeutic targets in leukemia. Blood, 102, 2969 2975.
24. Mizuki, M., Fenski, R., Halfter, H., Matsumura, I., Schmidt, R., Muller, C., Gruning, W., Kratz-Albers, K., Serve, S., Steur, C., Buchner, T., Kienast, J., Kanakura, Y., Berdel, W.E. Serve, H. (2000) Flt3 mutations from patients with acute myeloid leukemia induce transformation of 32D cells mediated by the Ras and STAT5 pathways. Blood, 96, 3907 3914.
25. Nakao, M., Yokota, S., Iwai, T., Kaneko, H., Horiike, S., Kashima, K., Sonoda, Y., Fujimoto, T. Misawa, S. (1996) Internal tandem duplication of the flt3 gene found in acute myeloid leukemia. Leukemia, 10, 1911 1918.
26. Noguera, N.I., Ammatuna, E., Zangrilli, D., Lavorgna, S., Divona, M., Buccisano, F., Amadori, S., Mecucci, C., Falini, B. Lo-Coco, F. (2005) Simultaneous detection of NPM1 and FLT3-ITD mutations by capillary electrophoresis in acute myeloid leukemia. Leukemia, 19, 1479 1482. (Pubitemid 41148948)
27. Olie, R.A., Hafner, C., Kuttel, R., Sigrist, B., Willers, J., Dummer, R., Hall, J., Stahel, R.A. Zangemeister-Wittke, U. (2002) Bcl-2 and bcl-xL antisense oligonucleotides induce apoptosis in melanoma cells of different clinical stages. Journal of Investigative Dermatology, 118, 505 512.
28. Ozeki, K., Kiyoi, H., Hirose, Y., Iwai, M., Ninomiya, M., Kodera, Y., Miyawaki, S., Kuriyama, K., Shimazaki, C., Akiyama, H., Nishimura, M., Motoji, T., Shinagawa, K., Takeshita, A., Ueda, R., Ohno, R., Emi, N. Naoe, T. (2004) Biologic and clinical significance of the FLT3 transcript level in acute myeloid leukemia. Blood, 103, 1901 1908.
29. Pallis, M., Seedhouse, C., Grundy, M. Russell, N. (2003) Flow cytometric measurement of phosphorylated STAT5 in AML: lack of specific association with FLT3 internal tandem duplications. Leukemia Research, 27, 803 805.
30. Pallisgaard, N., Clausen, N., Schroder, H. Hokland, P. (1999) Rapid and sensitive minimal residual disease detection in acute leukemia by quantitative real-time RT-PCR exemplified by t(12;21) TEL-AML1 fusion transcript. Genes, Chromosomes and Cancer, 26, 355 365.
31. Ponziani, V., Gianfaldoni, G., Mannelli, F., Leoni, F., Ciolli, S., Guglielmelli, P., Antonioli, E., Longo, G., Bosi, A. Vannucchi, A.M. (2006) The size of duplication does not add to the prognostic significance of FLT3 internal tandem duplication in acute myeloid leukemia patients. Leukemia, 20, 2074 2076.
32. Qian, Z., Fernald, A.A., Godley, L.A., Larson, R.A. Le Beau, M.M. (2002) Expression profiling of CD34+ hematopoietic stem/progenitor cells reveals distinct subtypes of therapy-related acute myeloid leukemia. Proceedings of the National Academy of Sciences of the United States of America, 99, 14925 14930.
33. Schnittger, S., Schoch, C., Dugas, M., Kern, W., Staib, P., Wuchter, C., Loffler, H., Sauerland, C.M., Serve, H., Buchner, T., Haferlach, T. Hiddemann, W. (2002) Analysis of FLT3 length mutations in 1003 patients with acute myeloid leukemia: correlation to cytogenetics, FAB subtype, and prognosis in the AMLCG study and usefulness as a marker for the detection of minimal residual disease. Blood, 100, 59 66.
34. Schnittger, S., Schoch, C., Kern, W., Mecucci, C., Tschulik, C., Martelli, M.F., Haferlach, T., Hiddemann, W. Falini, B. (2005) Nucleophosmin gene mutations are predictors of favorable prognosis in acute myelogenous leukemia with a normal karyotype. Blood, 106, 3733 3739.
35. Seedhouse, C.H., Hunter, H.M., Lloyd-Lewis, B., Massip, A.M., Pallis, M., Carter, G.I., Grundy, M., Shang, S. Russell, N.H. (2006) DNA repair contributes to the drug-resistant phenotype of primary acute myeloid leukaemia cells with FLT3 internal tandem duplications and is reversed by the FLT3 inhibitor PKC412. Leukemia, 20, 2130 2136.
36. Spiekermann, K., Dirschinger, R.J., Schwab, R., Bagrintseva, K., Faber, F., Buske, C., Schnittger, S., Kelly, L.M., Gilliland, D.G. Hiddemann, W. (2003a) The protein tyrosine kinase inhibitor SU5614 inhibits FLT3 and induces growth arrest and apoptosis in AML-derived cell lines expressing a constitutively activated FLT3. Blood, 101, 1494 1504.
37. Spiekermann, K., Bagrintseva, K., Schwab, R., Schmieja, K. Hiddemann, W. (2003b) Overexpression and constitutive activation of FLT3 induces STAT5 activation in primary acute myeloid leukemia blast cells. Clinical Cancer Research, 9, 2140 2150.
38. Stirewalt, D.L., Kopecky, K.J., Meshinchi, S., Engel, J.H., Pogosova-Agadjanyan, E.L., Linsley, J., Slovak, M.L., Willman, C.L. Radich, J.P. (2006) Size of FLT3 internal tandem duplication has prognostic significance in patients with acute myeloid leukemia. Blood, 107, 3724 3726.
39. Thiede, C., Steudel, C., Mohr, B., Schaich, M., Schakel, U., Platzbecker, U., Wermke, M., Bornhauser, M., Ritter, M., Neubauer, A., Ehninger, G. Illmer, T. (2002) Analysis of FLT3-activating mutations in 979 patients with acute myelogenous leukemia: association with FAB subtypes and identification of subgroups with poor prognosis. Blood, 99, 4326 4335.
40. Thiede, C., Koch, S., Creutzig, E., Steudel, C., Illmer, T., Schaich, M. Ehninger, G. (2006) Prevalence and prognostic impact of NPM1 mutations in 1485 adult patients with acute myeloid leukemia (AML). Blood, 107, 4011 4020.
41. Verhaak, R.G., Goudswaard, C.S., van Putten, W., Bijl, M.A., Sanders, M.A., Hugens, W., Uitterlinden, A.G., Erpelinck, C.A., Delwel, R., Lowenberg, B. Valk, P.J. (2005) Mutations in nucleophosmin (NPM1) in acute myeloid leukemia (AML): association with other gene abnormalities and previously established gene expression signatures and their favorable prognostic significance. Blood, 106, 3747 3754.
42. Whitman, S.P., Archer, K.J., Feng, L., Baldus, C., Becknell, B., Carlson, B.D., Carroll, A.J., Mrozek, K., Vardiman, J.W., George, S.L., Kolitz, J.E., Larson, R.A., Bloomfield, C.D. Caligiuri, M.A. (2001) Absence of the wild-type allele predicts poor prognosis in adult de novo acute myeloid leukemia with normal cytogenetics and the internal tandem duplication of FLT3: a cancer and leukemia group B study. Cancer Research, 61, 7233 7239.
43. Yamamoto, Y., Kiyoi, H., Nakano, Y., Suzuki, R., Kodera, Y., Miyawaki, S., Asou, N., Kuriyama, K., Yagasaki, F., Shimazaki, C., Akiyama, H., Saito, K., Nishimura, M., Motoji, T., Shinagawa, K., Takeshita, A., Saito, H., Ueda, R., Ohno, R. Naoe, T. (2001) Activating mutation of D835 within the activation loop of FLT3 in human hematologic malignancies. Blood, 97, 2434 2439.